Navigation Links
More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals

Drugs meant for treatment of Attention Deficit Hyperactivity Disorder (ADHD), Ritalin (Novartis AG) and Adderall (Shire Pharmaceuticals) would be subjected to stringent clinical trials to assess the safety and side effects // of the drug.

The decision has been taken following the reports of the U.S. advisory panel, which stated that strong warnings should be associated with marketing of such drugs. There is a possibility of sudden death, heart attacks and other complications associated with the use of the drug.

The company officials have expressed keen interest in evaluating the relationship between these drugs and cardiovascular risk, taking into consideration the physicians and affected patients. The company would also support disclosure of all information, including the warning statement.

Data from the prospective clinical trial is believed to be very crucial in deciding whether the drug should carry a black box warning. The black box warning is issue to a prescription drug that is related to dangerous side effects. When surveyed, 7 of the 8 panel members recommended a black box warning for the drug.

The drug Adderall, marketed by Shire already carries a black box warning, highlighting the possibility of sudden death or cardiovascular complications. More than 1 million ADHD prescriptions are being written for adults while children receive nearly 2 million prescriptions every year.

The ADHD drugs closely resemble amphetamines in chemical composition, known to cause hypertension, a significant predisposing factor for heart disease. With more clinical trials being planned, it would not be long before the safety of Adderall can be established.


'"/>




Page: 1

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer

Post Your Comments:
(Date:11/25/2009)...TO,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadi...tionsoftwarelaunchesasuiteofnewleadingedgeclinical...atformatthisyear,sRadiologicalSocietyofNorthAmeric...oth5800,HallA).Theapplicationsleveragetheuniquehig...Iimagingcoilsandsupportmultipleimagingmodalitiesfo...
(Date:11/25/2009)...GELES,Nov.25/PRNewswire-USNewswire/--TheBlackAIDSI...rmineexecutiveleadershipfor2010. ,, ThenewBoard...iesinpublicpolicy,law,finance,governmenthealthprog...dalsocomesfromawiderangeofpersonalbackgroundsinclu...ingwithHIVthemselves,andrepresentingmultipleagegro...
(Date:11/25/2009)...urvivors of testicular cancer who were treated wit...e effects, including neurological side effects and...ated with chemotherapy, according to a new study p... National Cancer Institute . , Marianne Brydy, M...ersity Hospital, in Bergen, Norway, and colleagues...
(Date:11/25/2009)... increase blood pressure? This simple question ha...s. New Stress-related gene Modulates High Blood P... pressure? This simple question has been the focu...earch has for the first time established a link be...ure response to stress in mice as well as humans. ...
(Date:11/25/2009)... Evaluation and treatment clinics to r...oodstock (Vocus) November 25, 2009 -- Centegra Hea...nes and H1N1 vaccine shots at four Centegra Primar...pment of vaccine has arrived. The clinics are at C...cHenry and will be open as follows: ,   ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...a,AFL-CIO President William George and Secretary T...ppointment in the latest decisions by,Representati...er to play,partisan politics with health insurance...ntatives Peterson, Pitts and Shuster could have ch...
...nson,Pharmaceutical Research & Development, L.L.C....ation (NDA) to the U.S. Food and Drug,Administrati...lease (IR),tablets, an investigational oral analge... each year as a result of injuries or,surgeries, a...
...ific (NYSE: BSX ),today issued the following stat... Scientific Officer, on an article in the New Engl...Bare-Metal and Drug-Eluting Stents for,Off-Label I...s the latest,in a series of studies that have led ...
... five years without anti-rejection drugs , ...es that allow organ transplant recipients to stop ...ng to come to fruition. , "The next stage in the d...s of the lifelong immunosuppressive drugs," said D...
...nthesis method based on a catalyst worth many time...ient and economical method than traditional ones f...rmaceutical compounds is described by its Universi...ium Technologies, LLC in Buffalo, has the potentia...
...ight to site of blood clot, study reports , ...s that attack blood clots directly in the brain ma...nd to the standard treatment using clot-busting dr...Fla. , Ischemic strokes -- which account for about...
Other Medicine News:Health News:Pennsylvania AFL-CIO Decries Shameful Votes Again by Representatives John Peterson, Joe Pitts and Bill Shuster, Against Children's Health Care 2Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 2Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 3Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 4Health News:Boston Scientific Comments on New England Journal of Medicine Article 2Health News:Boston Scientific Comments on New England Journal of Medicine Article 3Health News:New Therapies Could Change Organ Transplants 2Health News:New Therapies Could Change Organ Transplants 3Health News:New method enables design, production of extremely novel drugs 2Health News:New method enables design, production of extremely novel drugs 3Health News:Advanced Therapy Aids Stroke Patients 2Health News:Advanced Therapy Aids Stroke Patients 3
(Date:11/25/2009)...ALMBEACH,Fla.,Nov.25/PRNewswire-FirstCall/--Forman...ythe27millionlivingwithuntreated hearingloss ,theh...yer. ,, Dr.Beyer,seniorvicepresidentofHearUSA(A...ringaids companies,saidstudieshavelinkedhearinglos...easilybeintensifiedatholidaygatheringswithfamilies...
(Date:11/25/2009)...RK,Nov.25/PRNewswire/--Reportlinker.comannouncesth...e: ,, UnitedStatesDentalDevicesMarketAnalysisa...com/p0158733/United-States-Dental-Devices-Market-A...atesDentalDevicesMarketAnalysisandForecaststo2015 ...eforin-depthinformationanddatarelatingtotheUSdenta...
(Date:11/25/2009)...EGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(Na...ingproductsforminimallydisruptivesurgicaltreatment...cecallonMonday,November30,2009,at5:30p.m.ET/2:30p....tivetoreimbursementfortheCompany,sproductsandwilli...onandanswersession.Thedial-innumbersare1-877-407-4...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Orexigen 28R 29 Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings 12414 1Orexigen 28R 29 Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings 12414 2The Unexpected Gifts of Alzheimers 47597 1The Unexpected Gifts of Alzheimers 47597 2The Unexpected Gifts of Alzheimers 47597 3Spurwink Services Unveils Spruce Point 47593 1Spurwink Services Unveils Spruce Point 47593 2
...ew analysis of landmark study showed patients taki...nt of recurrent heart attack, stroke or cardiovas...opidogrel, TOKYO and INDIANAPOLIS, Aug. 21 A new...head-to-head TRITON-TIMI,38 study showed patients ...CS) managed with an artery-opening procedure known...
...NN ARBOR, Mich., Aug. 21 /PRNewswire/ Terumo Heart...U.S. patient implanted with the,DuraHeart(TM) Left...,discharged home on August 14th, from the Universi...ing the device., The patient is a 62-year-old man...om heart failure for nearly 20 years. He is the fi...
Other Medicine Technology:Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events 2Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events 3Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events 4Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events 5Discharge of First U.S. DuraHeart(TM) Patient 2
Replacement Bulb: HBO 50W/AC/L2
Replacement Bulb: ESA/FHD
Replacement Bulb: EJA
Replacement Bulb: EFM
Medicine Products: